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Components of the eukaryotic vaccinia virus/T7 RNA polymerase hybrid expression system were assessed using
recombinant and nonrecombinant forms of modified vaccinia Ankara (MVA), a replication-deficient vaccinia virus strain.
Recombinant MVA virus expressing T7 RNA polymerase (Wyatt, L. S., Moss, B., and Rozenblatt, S. (1995). Virology 210,
202–205) stimulated high levels of expression from a T7 promoter–chloramphenicol acetyltransferase (CAT) reporter. Most,
but not all, of the virally induced expression was T7 RNA polymerase and T7 promoter dependent, with no viral enhancement
of translation of T7 transcripts. The efficacy of supplying T7 RNA polymerase expression from nonviral sources was
evaluated using a self-amplifying T7 RNA polymerase autogene or an inducible T7 RNA polymerase expression vector. The
latter modes yielded CAT activity dependent on T7 RNA polymerase expression; however, expression required viral factors
independent of T7 RNA polymerase and did not reach that attained using the recombinant virus. In further experiments,
MVA-induced T7 RNA polymerase expression was upregulated by a-amanitin, an inhibitor of eukaryotic polymerases. This
indicates that MVA/T7 RNA polymerase hybrid expression may be rendered still more efficient by ameliorating transcrip-
tional interference due to an a-amanitin-sensitive eukaryotic factor(s). © 1998 Academic Press
INTRODUCTION
Bacteriophage enzymes such as T7 RNA polymerase
(T7RP) have been used with considerable success as
components of eukaryotic expression systems (Moss et
al., 1990; Deng et al., 1991; Gao and Huang, 1993; Chen
et al., 1994; Ward et al., 1995). In particular, T7RP-medi-
ated expression is highly efficient in eukaryotic cells
when coupled with vaccinia virus infection (Elroy-Stein
and Moss, 1990). Vaccinia virus/T7RP hybrid systems
allow levels of expression up to 30% of cellular RNA
(Fuerst and Moss, 1989) or approximately 10% of cellular
protein (Elroy-Stein and Moss, 1990). An attractive fea-
ture of the system is that transcription with the single
subunit phage polymerase is less dependent than host
polymerases on endogenous eukaryotic factors and
therefore is less susceptible to promoter effects inherent
in eukaryotic transcription complexes (Holter et al., 1991).
Furthermore, vaccinia virus-associated cytoplasmic ex-
pression using T7RP may circumvent the obligatory
translocation of transfected DNA to the nucleus required
of conventional eukaryotic promoters, thus bypassing a
major barrier to eukaryotic expression (Zabner et al.,
1995). Such aspects of T7 expression may allow expres-
sion less contingent on cell type, cellular metabolism, or
growth state than conventional mammalian expression
vectors.
Typically, when recombinant vaccinia viruses are used
to deliver target genes and/or T7RP, amplification of
target gene copy number, and hence enhancement of
expression, occurs as a consequence of both viral ge-
nome replication and spreading viral infection (Moss et
al., 1990). However, such vaccinia virus vectors encode
their own polymerase and transcription factors, have
pleiotropic effects on eukaryotic transcription and trans-
lation, and cause rapid cytopathic effects (Moss, 1990).
Thus, it would be very desirable to find conditions which
maintain the high level of expression typical of recombi-
nant viruses, but in which infection levels and viral ef-
fects are reduced or eliminated. In this regard, a recent
advance has been made through the use of an attenu-
ated vaccinia virus (modified vaccinia virus Ankara,
MVA), which does not give rise to infectious particles in
human cells and causes fewer cytopathic effects in cell
monolayers (Sutter and Moss, 1992). Expression using
this replication-deficient virus in a recombinant form de-
signed to deliver T7RP is comparable to, or higher than,
that of replicating virus (Sutter et al., 1995; Wyatt et al.,
1995), indicating that viral propagation is not absolutely
necessary to generate high expression. However, viral
DNA amplification of target genes as contained in the
attenuated MVA virus remains a factor.
Here, we report two experimental approaches which
dissociate the coding of T7RP from recombinant virus,
providing instead the requisite T7RP activity from a non-
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viral source. First, a self-amplifying T7RP autogene (the
T7RP gene under control of its own promoter) (Dubendorf
and Studier, 1991; Chen et al., 1994; Gao et al., 1994) was
constructed which yields high expression in vaccinia
virus-infected cells without the use of a recombinant
virus. Second, HeLa cell lines were constructed which
express inducible endogenous T7RP activity; these cells
likewise yield high levels of expression following infec-
tion with nonrecombinant virus. These approaches have
allowed us to address an unresolved issue in the use of
such vaccinia-based systems, namely, the extent to
which viral infection per se, as opposed to the level of
virus-encoded T7RP, enhances the expression of trans-
fected genes. Further, by dissociating T7RP activity from
recombinant virus, it has been possible to analyze in
greater detail how each of the components of the vac-
cinia virus/T7RP system (virus, T7RP, and target gene)
contributes to overall expression.
RESULTS
T7 promoter/T7RP-dependent expression using
a dual CMV/T7 promoter
The MVA strain of vaccinia virus was chosen for these
studies, since this strain aborts its replicative cycle at a
late-stage packaging step in human cells (Sutter and
Moss, 1992). Expression is thus achieved without prop-
agation of infectious virus. To test the ability of the
replication-deficient MVA virus to enhance expression,
HeLa cells were infected with either unmodified MVA or
a recombinant MVA strain modified to express T7RP
(Wyatt et al., 1995) (generous gifts from L. Wyatt and B.
Moss, National Institutes of Health). The cells were then
transiently transfected with identical plasmids containing
the CAT gene under control of the CMV promoter with or
without an included T7 promoter (Fig. 1). Infection by
MVA/T7RP resulted in a multifold increase in chloram-
phenicol acetyltransferase (CAT) activity upon transfec-
tion of pCMV[PT7]/CAT (Fig. 1, lane 1 vs lanes 3–7) which
was not observed for pCMV[2PT7]/CAT (Fig. 1, lane 10).
Lysates from MVA/T7RP-infected cells transfected with
pCMV[PT7]/CAT could be diluted up to 200-fold (Fig. 1,
lanes 4–7) before producing comparable acetylated
chloramphenicol levels achieved by pCMV[2PT7]/CAT
(Fig. 1, lane 10). The dual CMV and T7 promoters pro-
duced 440- and 3.5-fold (440 divided by 126) higher levels
of CAT expression than the CMV[2PT7] or T7 expression
units alone, respectively, in MVA/T7RP-infected cells (Ta-
ble 1). This represents 1200-fold higher activity than
when no CAT DNA was transfected (Fig. 1, lane 1 vs
lanes 3–7). Interestingly, an MVA-associated increase in
CMV expression was also evident which was T7RP
and T7 promoter-independent (Fig. 1, lane 8 vs lanes 9
and 10).
T7RP-dependent expression using T7 expression
vectors
An attractive feature of the vaccinia virus/T7RP expres-
sion system is its capacity for cytoplasmic expression
(Moss et al., 1990). Plasmids containing the CAT gene
under control of a T7 promoter, but devoid of eukaryotic
promoters, were constructed which contained 59 and 39
sequences designed to enhance expression of T7 tran-
scripts in eukaryotic cells. The 59 UTR from the encepha-
lomyocarditis (EMC) virus precedes the CAT gene and
confers cap-independent translation by acting as an in-
ternal ribosome entry site (IRES) (Jang et al., 1989). The
presence of a 59 EMC IRES has been shown to increase
eukaryotic expression of T7 transcripts 4- to 10-fold in
vaccina virus-infected cells (Elroy-Stein et al., 1989). Sim-
ilarly, the CAT gene is followed by a portion of the 39 UTR
from the Xenopus laevis b-globin gene and a polynucle-
otide tract of 30 adenine residues. This region has been
shown to increase eukaryotic expression of T7 RNA
transcripts, presumably by increasing their stability (Ma-
lone et al., 1989).
HeLa cells were transiently transfected with the PT7
expression vector, with or without the CAT gene, to test
the functionality of the T7 expression unit (Fig. 2). Al-
though no detectable CAT activity was observed for the
FIG. 1. Effect of MVA and MVA/T7RP infection on pCMV/CAT expres-
sion. HeLa cells were transfected with 1 mg pCMV/CAT DNA with
(lanes 1–7) or without (lanes 8–10) a T7 promoter in the absence of
infection (lanes 1 and 8) or in the presence of either 2 multiplicities of
infection (m.o.i.) MVA (lanes 2 and 9) or MVA/T7RP (lanes 3–7, 10). CAT
assays were performed for 2 h with 5 mg (lanes 1–3, 8–10) or the
indicated dilutions of 5 mg (lanes 3–7) of cell lysate. The products were
separated by thin layer chromatography (TLC), visualized by autora-
diography, and quantified by phosphorimaging.
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empty vector under any condition of infection (Fig. 2,
lanes 1–3) or for PT7/EMC/CAT/XbgA30 in the absence of
infection (Fig. 2, lane 4), MVA infection alone resulted in
increased CAT activity for PT7/EMC/CAT/XbgA30 DNA
(Fig. 2, lane 5), which was greatly enhanced after
MVA/T7RP infection (Fig. 2, lane 6). Quantitation of CAT
expression for PT7/EMC/CAT/XbgA30 DNA after MVA/
T7RP infection showed 126-fold higher expression than
pCMV[2PT7]/CAT (Table 1).
Effect of viral infection on T7 CAT RNA expression
Inasmuch as vaccinia virus does not influence the
uptake or trafficking of transfected DNA (Zabner et al.,
1995), the increased expression from PT7/EMC/CAT/
XbgA30 DNA after MVA/T7RP infection should be due
either to amplification of transfected DNA or increased
DNA transcription and/or translation of T7 transcripts.
Vaccinia virus-mediated amplification of DNA appears
unlikely since vaccinia-mediated increases in T7 expres-
sion occur in the presence of cytosine-b-D-arabino-
furanoside (AraC), an inhibitor of DNA synthesis (Elroy-
Stein and Moss, 1990). To eliminate translation as a
possibility, in vitro synthesized EMC/CAT/XbgA30 RNA
was transfected into HeLa cells, and CAT expression
was assayed under adjusted conditions of infection (Fig.
2). Compared to a tRNA control, which showed no de-
tectable CAT activity under any condition of infection (Fig.
2, lanes 7–9), transfected EMC/CAT/XbgA30 RNA showed
comparable levels of CAT activity in uninfected cells (Fig.
2, lane 10) or after MVA (Fig. 2, lane 11) or MVA/T7RP
infection (Fig. 2, lane 12). In each of these cases, expres-
sion did not approach that of PT7/EMC/T7RP/XbgA30
DNA (Fig. 2, lane 6).
T7RP autogene
Increasing the multiplicity of infection of MVA/T7RP
has been shown to increase expression of PT7 target
genes ((Wyatt et al., 1995) and data not shown). However,
it is unknown whether such increases are due to in-
creases in viral factors or the polymerase enzyme. To
dissociate MVA-associated versus T7RP-dependent ef-
fects on expression, a number of PT7/EMC/T7RP/XbgA30
autogenes were constructed (see Materials and Meth-
ods) so as to produce high levels of polymerase in the
absence of MVA/T7RP infection. Candidate autogenes
and pCMV[2PT7]/T7RP were tested for activity by ex-
pression of CAT from a cotransfected PT7/CAT reporter
gene after MVA infection. For active autogenes, T7RP
activity as measured by CAT expression increased lin-
early as the amount of transfected PT7/EMC/T7RP/
XbgA30 autogene DNA increased from 0 to 1.0 mg under
identical MVA infection levels (Fig. 3, lanes 1–6). How-
ever, increasing autogene levels further became inhibi-
tory (data not shown). Addition of the T7RP autogene to
MVA/T7RP-infected cells inhibited CAT expression by
approximately fourfold (126 divided by 35, Table 1). Al-
though an active pCMV[2PT7]/T7RP construct was also
made, its cotransfection together with the autogene did
not give increased expression over that observed with
the autogene alone (Table 1).
TABLE 1
Quantitation of CAT Activity Using Various Constructs
in Infected Cells
Plasmid
Infection Agent
(Relative activity)a
MVA MVA/T7RP
pCMV[2PT7]/CAT 1 1
pCMV[1PT7]/CAT 0.4 440
pCMV[2PT7]/CAT 1 1
pCITE/CAT/XbgA30
b 0.5 126
pCITE/CAT/XbgA30 1 AutoT7RP
c 8 35
pCITE/CAT/XbgA30 1 AutoT7RP 1
pCMV[2PT7]/T7RP 8 35
a HeLa cells were transiently transfected with the indicated plasmids
and CAT assays were performed as described. The relative activity is
expressed as the fold induction compared with that produced with
pCMV[2PT7]/CAT alone. The values in the top two lines are derived
from data depicted graphically in Fig. 1, while the bottom four lines
include additional data from the same experiment.
b The pCITE/CAT/XbgA30 expression unit consists of PT7/EMC/CAT/
XbgA30.
c The AutoT7RP expression unit consists of PT7/EMC/T7RP/XbgA30.
FIG. 2. MVA and MVA/T7RP infection increases CAT expression from
DNA but not RNA transfections. HeLa cells were transfected with 1 mg
of the T7 promoter/EMC IRES-bearing pCITE-2a plasmid without (lane
1–3) or with (lanes 4–6) CAT after no (lanes 1 and 4), 2 m.o.i. MVA (lanes
2 and 5), or 2 m.o.i. MVA/T7RP (lanes 3 and 6) infection. HeLa cells
were transfected with tRNA (lanes 7–9) or EMC/CAT/XbgA30 RNA
(lanes 10–12) in the absence of infection (lanes 7 and 10) or the
presence of 2 m.o.i. MVA (lanes 8 and 11) or 2 m.o.i. MVA/T7RP (lanes
9 and 12) infection. Cell extracts were analyzed for CAT activity as
described using 5 mg of lysate for 30 min, and the resultant autoradio-
graph is shown.
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Inducible T7RP activity in stable cell lines
HeLa cell lines expressing T7RP activity were gener-
ated by transfection and selection for cells bearing an
episomal plasmid containing the T7RP gene under con-
trol of a dexamethasone (DEX)-inducible promoter
(Mader and White, 1993; White et al., 1994). T7RP activity
(detected in 4 of 20 isolated cell lines) was tested under
induced conditions by expression of CAT from a trans-
fected PT7/EMC/CAT XbgA30 reporter gene after MVA
infection (Fig. 4). Although MVA-infected HeLa cells ex-
pressed CAT activity only in the presence of an exoge-
nous source of T7RP in the form of a cotransfected
autogene (Fig. 4A, lanes 7 and 8), MVA-infected HeLa/
GRE-T7RP cells exhibited increased CAT activity in the
absence of an exogenous source of T7RP and specifi-
cally under induced conditions (Fig. 4B, lane 4). CAT
activity under induced conditions (Fig. 4B, lane 4) was
slightly higher than that derived from the autogene in the
absence of induction (Fig. 4B, lane 7). However, cotrans-
fection of the T7RP autogene did not further increase
CAT activity in induced cells (Fig. 4B, lanes 4 and 8).
T7RP activity as measured by CAT expression was reg-
ulated by varying the levels of induction as CAT activity
correspondingly increased over the range of 0 to 250 nM
DEX (Fig. 4C, lanes 1–6).
Comparison of T7RP-mediated activities
The three modes of introducing productive amounts of
T7RP into cells (by MVA/T7RP infection, autogene trans-
fection, or induction in HeLa/GRE-T7RP cells) were com-
pared directly. HeLa cells or DEX-induced HeLa/GRE-
T7RP cells were infected with either MVA or MVA/T7RP
in the presence or the absence of the T7RP autogene
(Fig. 5). Addition of the T7RP autogene inhibited expres-
sion in all cases except in HeLa cells infected with MVA,
in which the autogene was the sole source of polymer-
ase (Table 1 and Fig. 5). The highest activity was
achieved with MVA/T7RP infection of HeLa cells not
expressing an endogenous source of T7RP (Table 1 and
Fig. 5, lanes 13 and 14). Expression in HeLa cells in-
creased with increasing amounts of target DNA (Fig. 5,
lanes 9–16, odd vs even lanes). Interestingly, HeLa/GRE-
T7RP cells did not show such a dependence on PT7
target DNA concentration (Fig. 5, lanes 1–8, odd vs even
lanes).
Effect of a-amanitin
The T7 promoter has been shown to bind to eukaryotic
nuclear factors and to act as a transcription start site for
RNA polymerase II in eukaryotic cells (Sandig et al.,
1993; Ba¨hring et al., 1994). The fungal peptide toxin
a-amanitin, which inhibits eukaryotic but not prokaryotic
or vaccinia polymerases (Nevins and Joklik, 1977; Ba-
roudy and Moss, 1980), was employed to investigate
whether eukaryotic factors were involved in vaccinia
virus MVA/T7RP expression. PT7/EMC/CAT/XbgA30 ex-
pression units were placed in the streamlined plasmid
pMINI-S so as to reduce the potential for nonspecific
transcription. The pMINI-S plasmids contain a limited
amount (1812 bp) of DNA encoding an origin and an
FIG. 4. Induction of T7RP activity in stable cell lines. (A) HeLa cells
were transfected with 1 mg PT7/EMC/CAT/XbgA30 reporter DNA without
(lanes 1–4) or with (lanes 5–8) 1 mg of T7RP autogene. Cells were either
uninfected (lanes 1, 2, 5, and 6) or infected with MVA (lanes 3, 4, 7, and
8) under uninduced or induced conditions as indicated. Induction
occurred with 25 nM DEX after the 6-h transfection period for an
additional 24 h. CAT activity was measured and the resultant autora-
diograph is shown. (B) HeLa/GRE-T7RP cells were treated identically
as in A. (C) HeLa/GRE-T7RP cells induced with 0 (lane 1), 0.025 (lane 2),
0.25 (lane 3), 2.5 (lane 4), 25 (lane 5), or 250 nM (lane 6) DEX were
transfected with 1 mg PT7/EMC/CAT/XbgA30 DNA. CAT assays were
performed on an equivalent 1 mg of protein, for 45 min, the radiolabeled
products analyzed by TLC, and the resultant autoradiograph is shown.
FIG. 3. Increasing addition of T7RP autogene results in increasing
CAT expression. HeLa cells were infected with 2 m.o.i. MVA and
transiently cotransfected with 1 mg of T7 promoter/EMC/CAT/XbgA30-
bearing plasmids with 0 (lane 1), 0.01 (lane 2), 0.05 (lane 3), 0.1 (lane 4),
0.5 (lane 5), or 1.0 (lane 6) mg of T7RP autogene. Cell extracts were
prepared, normalized for protein content, and analyzed for CAT activity.
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ampicillin resistance gene as a backbone (Humphry et
al., 1996). To test the efficacy of introducing a-amanitin
into eukaryotic cells via lipofection, the CAT gene under
control of the eukaryotic CMV promoter was transfected
into HeLa cells in the absence or the presence of
a-amanitin peptide (Fig. 6A). Decreased CAT activity was
observed in the presence of a-amanitin, consistent with
its inhibitory activity on eukaryotic polymerases (Fig. 6A,
lanes 1 and 2). In contrast, expression from the trans-
fected pMINI-S/CAT construct was enhanced in the pres-
ence of a-amanitin (Fig. 6B, lanes 2–5) compared to its
absence (Fig. 6B, lane 1).
EMC/CAT/XbgA30 expression units were also con-
structed under control of a wild-type T7 promoter, no T7
promoter, or a mutated T7 promoter. The modified T7
promoter was generated from a screen to isolate func-
tional T7 promoters which have decreased ability to bind
HeLa cell proteins in gel-shift assays (Lieber et al.,
1993b). Both the T7 wild-type and mutated promoters but
not the promoterless CAT constructs produced CAT pro-
tein in coupled in vitro transcription/translation reactions
in reticulocyte lysates (Fig. 7A, lanes 1–3). CAT con-
structs with a T7 wild-type promoter, lacking a T7 pro-
moter or containing a mutated T7 promoter, were also
transfected into HeLa cells in the absence or the pres-
ence of a-amanitin along with T7RNA polymerase in the
form of a PT7/EMC/T7RNP/XbgA30 autogene (Fig. 7B).
The cells were then infected with MVA. The wild-type T7
promoter gave increased expression of CAT activity in
the presence of a-amanitin compared to its absence, the
difference being a sixfold increase when quantitated by
phosphorimager analysis (Fig. 7B, lanes 1 and 4). Ex-
pression from the PT7-less CAT construct was also en-
hanced in the presence of a-amanitin (Fig. 7B, lanes 2
and 5); however, the mutated T7 promoter showed only a
threefold activation of CAT activity in the presence of
a-amanitin (Fig. 7B, lanes 3 and 6).
DISCUSSION
The multicomponent vaccinia virus/T7RP eukaryotic
expression system consists of a target gene (or genes)
under control of a T7 promoter, the bacteriophage T7RP,
and vaccinia virus-associated factors. The high tran-
scriptional activity of T7RP coupled with vaccinia virus-
enhanced expression of T7 transcripts allows high pro-
tein expression levels in cultured eukaryotic cells (Moss
et al., 1990; Ward et al., 1995). We describe use of the
vaccinia virus/T7RP system with a previously described
replication-deficient vaccinia virus strain (Sutter and
FIG. 6. Effect of a-amanitin on MVA/T7RP-mediated expression. (A)
HeLa cells infected with 2 m.o.i. MVA were cotransfected with 1 mg
pCMV[2PT7]/CAT without (lane 1) or with (lane 2) 10 mg a-amanitin. Cell
lysates were prepared and analyzed for CAT activity using 10 mg of
protein for 2 h. The resultant autoradiograph is shown. (B) A pMINI-S
plasmid containing PT7/EMC/CAT/XbgA30 was transfected in MVA/
T7RP-infected cells without (lane 1) or with 2 (lane 2) 5 (lane 3), 10 (lane
4), or 20 (lane 5) mg a-amanitin. Cell lysates were prepared and
analyzed for CAT activity, with the resulting autoradiograph shown.
FIG. 5. Comparison of MVA/T7RP expression. Dexamethasone-induced HeLa/GRE-T7RP (lanes 1–8) or HeLa cells (lanes 9–16) were infected with
2 m.o.i. MVA (lanes 1–4, 9–12) or MVA/T7RP (lanes 5–8, 13–16) and cotransfected with or without 1 mg T7RP autogene as indicated with either 1 or
10 mg of PT7/EMC/CAT/XbgA30 reporter (odd- and even-numbered lanes, respectively). Twenty-four hours after transfection, cells were lysed and
analyzed for CAT activity using 100 ng lysate for 30 min. The insert shows samples 9–12 analyzed for CAT activity using 10 times more lysate (1 mg)
for 30 min in order to visualize the activity. The resultant autoradiogram of separated products is shown.
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Moss, 1992). The MVA strain has yielded high expression
with reduced cytopathic effects and allowed analysis of
expression independent of viral replication (Sutter et al.,
1995; Wyatt et al., 1995). We find, as previously observed
(Sutter et al., 1995; Wyatt et al., 1995), that MVA/T7RP-
mediated expression allows high expression, despite
being replication deficient. In addition, these results
were achieved with the relatively low multiplicity of 2
infectious units. At this level, high expression was ob-
served for the CAT gene with both CMV/PT7 and PT7
expression units, with the dual CMV/PT7 promoter giving
the highest overall expression (440-fold over the CMV
promoter alone).
T7 RNA polymerase from nonviral templates
Two methods were employed to control the amount of
T7RP activity in the vaccinia virus/T7RP expression sys-
tem apart from varying MVA/T7RP infection: (i) varying
the amounts of a self-amplifying T7RP autogene or (ii)
modulating the levels of T7RP induction in dexametha-
sone-regulatable stable cell lines. Transfection of low
levels of autogene DNA and expression from induced
HeLa/GRE-T7RP cells both yielded far higher CAT ex-
pression than that achieved by the CMV promoter. Use of
pCMV[2PT7]/T7RP as a ‘‘primer’’ in the autogene system
did not improve CAT expression over that obtained with
the autogene alone. The option of dispensing with such
a primer plasmid is fortunate, as pCMV[2PT7]/T7RP ex-
pression requires nuclear localization and thus is inher-
ently limiting in the cytoplasmic vaccinia virus expres-
sion system.
Increasing T7RP activity by either autogene addition or
induction in HeLa/GRE-T7RP cells yielded quantitive in-
creases in reporter gene expression, independent of
increases in viral factors. However, elevating autogene
levels beyond a certain point eventually inhibited expres-
sion, and autogene addition to cells already expressing
T7RP from MVA/T7RP infection, or from an inducible
GRE-T7RP plasmid, either did not further increase or
significantly inhibited expression. Indeed, an apparent
limit appears to exist above which increasing T7RP lev-
els independent of the virus does not yield a concomitant
increase in target gene expression. A potential explana-
tion for this is that, as in prokaryotes (Tabor and Rich-
ardson, 1985; Studier and Moffatt, 1986), high levels of
T7RP and its promoter are toxic. Therefore, it may be
advantageous to deliver amounts of T7RP just sufficient
so as not to be limiting. Overall, viral delivery of T7RP
yielded the highest amounts of CAT gene expression at
the infection levels utilized.
Transcriptional vs translational mechanisms
Stimulation of T7RP-directed expression in eukaryotic
cells by vaccinia virus appears to be transcriptional
since: (1) expression is stimulated by vaccinia virus in
the presence of an inhibitor of DNA replication (AraC),
eliminating plasmid DNA amplification as a factor (Elroy-
Stein and Moss, 1990); (2) Northern analysis shows T7RP
levels increase during vaccinia infection (Elroy-Stein and
Moss, personal communication); and (3) CAT expression
from transfected EMC/CAT/XbgA30 RNA is not stimulated
by vaccinia virus infection, arguing against a posttran-
scriptional mechanism (this report). In our study, it re-
mains possible that expression from exogenously added
EMC/CAT/XbgA30 RNA was not efficiently coupled to
translation pathways in vivo, similar to effects shown
with other expression systems using heterologous com-
ponents (Lewicki et al., 1993; Iost and Dreyfus, 1994,
1995; Chao et al., 1995). As concerns the effects of
vaccinia virus on T7 transcription, these may be direct,
such as through the activity of viral polymerase and
associated factors, or indirect, such as through optimal
localization of the transfected plasmid with viral or cel-
lular components.
Hybrid characteristics of the expression system
By measuring CAT reporter activity with or without T7
promoter control, in combination with virus either encod-
ing or not encoding T7RP, it could be shown that MVA/
T7RP-mediated expression is truly a hybrid system, con-
sisting predominantly of a T7RP-mediated component,
but also of a MVA-associated component. The T7RP
FIG. 7. Effect of a-amanitin on CAT expression from a wild-type T7
promoter, no T7 promoter, or a mutated T7 promoter. (A) pMINI-S
plasmids containing EMC/CAT/XbgA30 under control of a T7 promoter
(lane 1), no T7 promoter (lane 2), or a mutated T7 promoter (lane 3)
were used to prime in vitro transcription/translation reactions. The
radiolabeled proteins were separated by SDS–PAGE and visualized by
autoradiography. (B) HeLa cells were infected with 2 m.o.i. of MVA and
cotransfected with 1 mg of T7RP autogene and 1 mg each of pMINI-S
plasmid containing EMC/CAT/XbgA30 under control of a T7 promoter
(lanes 1 and 4), no T7 promoter (lanes 2 and 5), or a mutated T7
promoter (lanes 3 and 6) in the absence or the presence of 10 mg
a-amanitin as indicated. Cell extracts were analyzed for CAT activity
using 1 mg protein for 30 min as described and the resultant autora-
diograph is shown. The CAT assays shown in B were quantified by
phosphorimaging (see text). The sequences of both wild-type and
mutated T7 promoter regions are shown with stars indicating the sites
of mutation.
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activity is PT7 dependent, while the MVA-associated com-
ponent is PT7 and T7RP independent. MVA-associated
activity may reflect transcription from otherwise cryptic
start sites by vaccinia virus-derived polymerase and as-
sociated factors, possibly as has been reported for the
CAT coding sequence (Ryan, 1992), as well as high
translation efficiencies for RNAs with a 59 EMC IRES.
Unlike translation initiation of capped eukaryotic tran-
scripts, the EMC IRES enhances translation of juxta-
posed downstream genes regardless of its position
within RNA and independent of 59 free ends (Chen and
Sarnow, 1995). In addition, MVA-encoded factors are
likely to activate the T7RP autogene, which initiates ex-
pression in the presence of MVA infection but absent
other sources of T7RP. Theoretically, since only one poly-
merase molecule is able to initiate the amplification
process, the autogene is a sensitive measure of tran-
scription in infected eukaryotic cells.
Interference by eukaryotic factors
The opposite effects of a-amanitin in inhibiting
pCMV[2PT7]/CAT activity but increasing MVA/T7RP-
mediated CAT expression suggest that the a-amanitin pep-
tide acts by discriminating between eukaryotic and non-
eukaryotic transcription in the hybrid system. Since T7RP-
mediated CAT expression was not inhibited by a-amanitin,
expression appears due to phage polymerase and vaccinia
factors as opposed to a-amanitin-sensitive eukaryotic fac-
tors. The increase in expression from PT7/CAT and PT7-less/
CAT plasmids by a-amanitin suggests that both T7RP-
mediated and MVA-associated expression may be suscep-
tible to eukaryotic factors repressing expression; however,
a-amanitin-induced alterations in viral action cannot be
excluded. The former interpretation is supported by reports
showing (1) HeLa cell nuclear factors bind T7 plasmids
(Sandig et al., 1993); (2) the T7 promoter acts as a RNA
polymerase II start site (Ba¨hring et al., 1994); and (3) eu-
karyotic RNA polymerase II interferes with expression from
downstream promoters through which it transcribes (Cullen
et al., 1984; Proudfoot, 1986; Corbin and Maniatis, 1989).
The increase in PT7/CAT activity caused by a-amanitin
might then be due to the clearing of eukaryotic polymerase
and/or associated factors from the T7 plasmid. This would
allow increased expression from T7RP and MVA-associ-
ated factors. Consistent with this, we report that a mutated
T7 promoter which is less able to bind HeLa nuclear factors
(Lieber et al., 1993b) appears less stimulated by a-amanitin.
Understanding the effects of repressive eukaryotic factors
may lead to methods of further enhancing vaccinia virus/
T7RP-mediated expression in eukaryotic cells.
MATERIALS AND METHODS
Plasmid construction
Using VENT polymerase (New England Biolabs) and
standard thermocycling procedures to add restriction en-
zyme sites suitable for cloning, the CAT gene was sub-
cloned into the HindIII/XhoI sites of pCMV.3 (Orgryzko et al.,
1994), a eukaryotic expression vector containing both a
CMV and a T7 promoter (PT7), which is referred to as
pCMV[PT7]/CAT. The CAT gene was similarly subcloned
into the HindIII/XhoI sites of pCMV[2PT7], which is identical
to pCMV[PT7] except for deletion of PT7. The CAT gene was
also subcloned into the NcoI/XhoI sites of the pCITE-2a
vector (Novagen) modified to contain the Xenopus laevis
b-globin 39 untranslated region (UTR) from pEMCLucXbgAn
(Deng et al., 1991), a gift from J. Wolff, University of Wiscon-
sin) followed by a polynucleotide tract of 30 adenine resi-
dues (XbgA30). The pCITE-2a vector as supplied contains a
T7 promoter and an IRES for eukaryotic ribosomes derived
from the EMC virus 59 UTR. The CAT gene flanked by the
EMC 59 UTR from pTM1 (Moss et al., 1990; a gift from B.
Moss, National Institutes of Health) and the XbgA30 39 UTR
was also placed under a T7 promoter, no T7 promoter, or a
modified T7 promoter (Lieber et al., 1993a,b) and this ex-
pression unit was subcloned into the pMINI-S plasmid
(Humphry et al., 1996) modified to contain the multiple
cloning site from pUC19. The pMINI-S T7 expression units
contain the lac operator originally derived from pET-21(1)
followed by a stem-loop structure previously shown to en-
hance RNA stability (Fuerst and Moss, 1989).
The T7RP autogene was made using thermocycling
procedures to add restriction enzyme sites to the T7RP
gene derived from pAR1173 (American Tissue Type Cul-
ture 39562). An extra codon (GGA) was added following
the initiating ATG so as to provide an NcoI site. There-
fore, the expressed protein contains an added glycine
residue following the initial methionine. Modification of
the T7RP amino terminus appears not to effect its activity
adversely (Dunn et al., 1988). The T7RP insert was sub-
cloned into the NcoI/XhoI sites of the pET-21(1) vector
(Novagen) modified to contain the EMC 59 UTR, including
a 59 stem-loop structure (Fuerst and Moss, 1989), and the
XbgA30 39 UTR. This plasmid retains the T7lac promoter/
operator and lacI gene required for repression during
propagation in bacteria and a T7 terminator. The T7RP
gene was also subcloned into the HindIII/XhoI sites of
pCMV[2PT7] and the NcoI/XhoI sites of pCITE-2a (Nova-
gen). The functionality of both CAT and T7RP T7 expres-
sion units was tested using coupled in vitro transcription/
translation reactions in reticulocyte lysates (Promega)
with [35S]methionine (New England Nuclear). Reactions
were subjected to SDS–PAGE and visualized by fluorog-
raphy to detect the expected protein products.
Propagation of plasmids containing the T7RP gene
under control of its own promoter (T7RP autogene) is
toxic to bacteria and strongly selects for nonfunctional
forms (Dubendorf and Studier, 1991). Bacteria bearing
functional T7RP autogenes were viable only under con-
ditions when T7RP RNA expression was repressed by
the lacI gene product and T7RP protein activity was
inhibited by T7 lysozyme (Dubendorf and Studier, 1991).
lacI repression alone was sufficient for the generation of
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functional PT7/EMC/T7RP autogenes (i.e., the presence
of T7 lysozyme as expressed from pLysS or pLysE plas-
mids (Dubendorf and Studier, 1991) was not necessary
(data not shown). This relaxed stringency may be due to
the presence of the EMC 59 IRES which may inhibit
production of functional polymerase in prokaryotes and
lower the requirement for repression of autogene activity.
Vaccinia virus infection and liposome-mediated
transfection
HeLa cells were grown in Dulbecco’s modified Eagle’s
medium (DMEM) (Life Technologies, Inc.) containing 10%
(v/v) fetal bovine serum (FBS) (Hyclone) in humidified air,
5% CO2 at 37°C. For transfections, cells were seeded in
24-well plates at 300,000 cells per well. Cells were
washed with reduced serum media (OPTI-MEM; Life
Technologies, Inc.) and unmodified MVA virus or recom-
binant MVA expressing T7RP (gifts of L. Wyatt and B.
Moss, National Institutes of Health) was added at indi-
cated infection levels in 200 ml OPTI-MEM/well for 30
min. During the infection period, DNA and lipid transfec-
tion reagents were mixed and incubated for 30 min at
room temperature. DNA was purified by CsCl double-
band ultracentrifugation (Fordis and Howard, 1987). Ra-
tios of DNA:lipid of 1:2.5 or 1:5 (w/w) with LipofectACE or
DMRIE-C (Life Technologies, Inc.) were used in 1 ml
OPTI-MEM. After the infection period, the cells were
washed and the DNA/lipid precipitates were added for
6 h. The lipofection mixes were washed away and cells
were harvested 24 h postinfection initiation. Gene ex-
pression was measured in the cell lysates by assaying
for CAT activity (Fordis and Howard, 1987). CAT activity
was quantitated by thin-layer chromatography and phos-
phorimaging. If conversion of greater than 80% of chlor-
amphenicol occurred, the assay was considered out of
the linear range and lysates were diluted appropriately
for quantification. The extreme sensitivity of the CAT
assay allowed readily detectable expression with an
infectivity of only 2 multiplicities of infection (m.o.i.), an
amount that would not be expected to infect all cells but
allowed a reduction of viral side effects.
RNA preparation and transfection
Plasmids containing the CAT gene flanked by a 59
EMC and a 39 XbgA30 UTR and preceded by a T7 pro-
moter were linearized with BglII which cleaves at the
terminal 39 adenine residue in the artificial A30 tract.
Uncapped RNA was transcribed in vitro using T7RP
(MEGAscript High Yield Transcription Kit; Ambion, Inc.)
and isolated by LiCl precipitation. For RNA transfections,
HeLa cells were infected and transfected as described
above except the ratio of RNA:LipofectACE was 1:2 (w/w)
using 1 mg CAT RNA with 3 mg tRNA as carrier in 1 ml
OPTI-MEM. The cells were harvested 24 h postinfection
initiation.
Generation of stable cell lines
The pGRE5-1/EBV plasmid (Mader and White, 1993;
White et al., 1994; a generous gift from J. H. White, McGill
University, Montreal) is an Epstein–Barr virus (EBV)-
based episomal mammalian expression vector contain-
ing the EBV nuclear antigen (EBNA) gene and a series of
five glucocorticoid response elements (GRE) which acti-
vates transcription in the presence of dexamethasone
(DEX). A BamHI fragment containing the T7RP gene was
excised from pAR1173 (American Tissue Type Collection
39562) and oriented appropriately into the BamHI site of
pGRE5-1/EBV. DNA was purified by anion-exchange
chromatography (QIAGEN, Inc.) and HeLa cells were
transfected by electroporation as described (Goldstein et
al., 1989) except without the addition of sodium butyrate.
Cells were incubated in DMEM/10% FBS for 48 h after
transfection before selection was initiated in 250 mg/ml
hygromycin (Boehringer Mannheim Biochemicals) with
the media changed every 2–3 days. After 4 weeks of
selection, cell colonies were isolated and expanded.
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